diabetes

Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law
RAPS.org
Fri, 10/4/19 - 11:24 pm
Nevada
drug pricing
diabetes
‘Smart’ Inhaler Can Make Insulin Delivery Quick and Painless
Xtalks
Fri, 10/4/19 - 09:57 am
Aerami Therapeutics
insulin
smart inhalers
diabetes
Judge Dismisses ‘White Coat’ Whistleblower Allegations Against Bayer, Eli Lilly
BioSpace
Fri, 10/4/19 - 09:49 am
Bayer
Eli Lilly
Humalong
Humulin
diabetes
whistleblower lawsuits
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
Fri, 09/27/19 - 09:10 am
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
Can Synthetic Biology Make Insulin Faster, Better and Cheaper?
Forbes
Sat, 09/21/19 - 12:39 pm
diabetes
insulin
drug pricing
Genentech
gene editing
Sigilon Therapeutics approaches the clinic
EP Vantage
Thu, 09/19/19 - 08:11 pm
Sigilon
orphan drug
hemophilia A
Eli Lilly
diabetes
Novo and Sanofi make case for hypo-reducing insulins at EASD
Pharmaforum
Thu, 09/19/19 - 09:59 am
Novo Nordisk
Sanofi
EASD
diabetes
hypoglycemia
insulin
Lantus
Tresiba
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Wed, 09/18/19 - 09:53 am
Novo Nordisk
Eli Lilly
oral semaglutide
Trulicity
diabetes
EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win
Fierce Pharma
Tue, 09/17/19 - 03:41 pm
Novo Nordisk
Ozempic
JNJ
Invokana
Victoza
diabetes
EASD
Factbox: Britain's insulin providers prepare for Brexit fallout
Yahoo/Reuters
Tue, 09/17/19 - 10:05 am
Novo Nordisk
Eli Lilly
Sanofi
UK
Brexit
insulin
diabetes
AstraZeneca diabetes drug granted fast track status for heart failure treatment
Yahoo/Reuters
Mon, 09/16/19 - 09:28 am
AstraZeneca
Farxiga
heart failure
diabetes
FDA
fast track
Novo Nordisk and Medtronic to integrate diabetes technology
Pharmaforum
Mon, 09/16/19 - 09:20 am
Novo Nordisk
Medtronic
diabetes
devices
blood glucose monitoring
ICER dings Novo's new oral diabetes drug
Biopharma Dive
Wed, 09/11/19 - 11:41 pm
Novo Nordisk
diabetes
ICER
oral semaglutide
Eli Lilly
Boehringer Ingelheim
Jardiance
Ozempic
Sanofi paying Lexicon $260M to exit diabetes alliance
BioPharma Dive
Wed, 09/11/19 - 12:51 pm
Sanofi
Lexicon Pharmaceuticals
diabetes
type 1 diabetes
Zynquista
Xeris scores first FDA nod with shelf-stable glucagon injector
Fierce Pharma
Wed, 09/11/19 - 10:20 am
Xeris Pharmaceuticals
FDA
glucagon
Gvoke
diabetes
Novo Nordisk to cut insulin prices for some U.S. diabetics
Yahoo/Reuters
Fri, 09/6/19 - 10:08 am
Novo Nordisk
drug pricing
Novolog
insulin
diabetes
A battered Zafgen seeks strategic options, prophesying ongoing study will unlikely lift FDA hold on diabetes drug
Endpoints
Thu, 09/5/19 - 10:32 am
Zafgen
diabetes
FDA
ZGN-1061
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Tue, 09/3/19 - 10:32 am
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Fierce Pharma
Tue, 09/3/19 - 10:24 am
Mylan
Lantus
generics
Biocon
drug manufacturing
diabetes
Heart failure results could unlock key market for Farxiga – AZ
Pharmaforum
Mon, 09/2/19 - 12:22 pm
AstraZeneca
heart failure
diabetes
Farxiga

Pages